Improved MRD Negativity Rates in Adverse Genomic Risk B-ALL Patients with Chemotherapy / Blinatumomab Induction: Experience from the Australasian Leukaemia Lymphoma Group (ALLG) ALL06/09 StudiesDeborah L White,Jacqueline A Rehn,Caitlin E Schutz,Susan L Heatley,Laura N Eadie, Ashlee Thomson,Elyse C Page,Michael Osborn,Shane Gangatharan,Ashley P Ng,Shaun Fleming,Pasquale Fedele,Toby Trahair,John Casey,Sally Mapp,Carol CY Cheung,Tasman Armytage,Michelle Henderson,Rosemary Sutton,Stephen Robert LarsenBlood（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
